Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children

Autor: Victor Turcanu, George Du Toit, Susan M H Chan, Shih-Ying Wu, Adam T. Fox, Abdel Douiri, Alexandra F. Santos, Gideon Lack, Suzana Radulovic, Natalia Bécares, Alick Stephens

Publikováno v: Santos, A, Douiri, A, Bécares, N, Wu, S, Stephens, A, Radulovic, S, Chan, S M H, Fox, A T, Du Toit, G, Turcanu, V & Lack, G 2014, ' Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children ', Journal of Allergy and Clinical Immunology, vol. 134, no. 3, pp. 653-654 . https://doi.org/10.1016/j.jaci.2014.04.039
The Journal of Allergy and Clinical Immunology

Background:Most of the peanut-sensitized children do not have clinical peanut allergy. In equivocal cases, oral food challenges (OFCs) are required. However, OFCs are laborious and not without risk; thus, a test that could accurately diagnose peanut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::138171047bffb38c37c23c41de5bed1f
https://doi.org/10.1016/j.jaci.2014.04.039

Cutaneous lymphocyte antigen and α4β7 T-lymphocyte responses are associated with peanut allergy and tolerance in children

Autor: Adam T. Fox, Susan M H Chan, Andrew P. Grieve, Victor Turcanu, Gideon Lack, Alick Stephens

Publikováno v: Allergy. 67:336-342

Background: It is unclear whether the initial route of allergen exposure in early life could influence the subsequent development of allergy, with cutaneous sensitization leading to peanut allergy (PA), and tolerance induced by oral exposure. The ski

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd98070b4d9a65e975bf09edca16b8ce
https://doi.org/10.1111/j.1398-9995.2011.02765.x

Role of leukotriene receptor antagonists in the management of pediatric asthma: an update

Autor: Catalina, Dumitru, Susan M H, Chan, Victor, Turcanu

Publikováno v: Paediatric drugs. 14(5)

At present, the main indications for leukotriene receptor antagonists (LTRA) in pediatric asthma are as add-on therapy to inhaled corticosteroids (ICS) and as initial controller therapy in children with mild asthma, especially those who cannot or wil

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cd9a4302cdbf0c8b745ea87aa62bcf84
https://pubmed.ncbi.nlm.nih.gov/22897162